Apex Healthcare Bhd's EBIT per Share for the
three
months ended in Sep. 2025 was RM0.03.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was RM0.13.
During the past 12 months, the average EBIT per Share Growth Rate of Apex Healthcare Bhd was 3.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 16.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 8.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Apex Healthcare Bhd's EBIT per Share or its related term are showing as below:
XKLS:7090'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 0.6 Med: 9.75 Max: 16.2
Current: 16.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Apex Healthcare Bhd was 16.20% per year. The lowest was 0.60% per year. And the median was 9.75% per year.
XKLS:7090's 3-Year EBIT Growth Rate is not ranked
in the Medical Distribution industry.
Industry Median: 4.2
vs XKLS:7090: 16.20
Apex Healthcare Bhd (XKLS:7090) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Apex Healthcare Bhd EBIT per Share Related Terms
Apex Healthcare Bhd EBIT per Share Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd (XKLS:7090) has a EBIT per Share of RM0.13 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Apex Healthcare Bhd and its competitors.
Is Apex Healthcare Bhd's EBIT per Share too high?
Apex Healthcare Bhd's current EBIT per Share is RM0.13. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's EBIT per Share compare to MCK and COR?
Apex Healthcare Bhd's EBIT per Share of RM0.13 can be compared against companies in the Medical Distribution industry. The industry median EBIT per Share is 4.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current EBIT per Share is RM0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current EBIT per Share of RM0.13. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current EBIT per Share is RM0.13. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current EBIT per Share is RM0.13 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
EBIT per Share: RM0.13
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
